Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09DWL
|
||||
Former ID |
DAP000266
|
||||
Drug Name |
Zaleplon
|
||||
Synonyms |
Sonata; Zalaplon; Zerene; CL 284846; L 846; L846; LJC 10846; ZAL 846; AZ-007; CL 284,846; CL-284846; CL284,846; L-846; LJC-10846; SKP-1041; Sonata (TN); Staccato-zaleplon; Starnoc (TN); ZAL-846; Zaleplon [USAN:INN]; Zaleplon (JAN/USAN/INN); N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide; N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide; 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide; 3'-(3-Cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-N-ethylacetanilide
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Hypnotics and Sedatives
|
||||
Company |
King Pharm
|
||||
Structure |
Download2D MOL |
||||
Formula |
C17H15N5O
|
||||
InChI |
InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3
|
||||
InChIKey |
HUNXMJYCHXQEGX-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 151319-34-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9687, 5366116, 7847596, 8153504, 12014056, 14751928, 26719706, 29216208, 29224756, 46386657, 46508267, 48416707, 49831110, 49858710, 50064487, 57288874, 57322911, 58107163, 76325725, 81041179, 81093138, 87246409, 92308631, 92714203, 93166204, 103558703, 104179081, 104310058, 104829286, 124360324, 124659160, 125341659, 126629628, 126655581, 126669582, 128115429, 131299907, 134337580, 135017416, 135698186, 135710033, 136352570, 136897476, 137001621, 142240621, 144089038, 144205425, 160964301, 162011443, 162022385
|
||||
SuperDrug ATC ID |
N05CF03
|
||||
SuperDrug CAS ID |
cas=151319345
|
||||
Target and Pathway | |||||
Target(s) | Gamma-aminobutyric acid receptor subunit alpha-1 | Target Info | Modulator | [556264] | |
References | |||||
Ref 467682 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4345). | ||||
Ref 538325 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 077237. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.